Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Sarah Wambacq, Beatrice Gulbis, Fleur Samantha Benghiat, Bénédicte Brichard, Bruwier Annelyse, Laurence Dedeken, Bram De Wilde, Marie-Françoise Dresse, Andre Efira, Catherine Heijmans, Veerle Labarque, Phu-Quoc Le, Philip Maes, Pierre Philippet, An Van Damme, Anna Vanderfaeillie, Alina Ferster

Blood (2021) 138 (Supplement 1): 4171.

https://doi.org/10.1182/blood-2021-145403

Published: 2021

Journal Articles

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Clemence Peresse, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Beatrice Gulbis, MD PhD, Sarah Wambacq, Alina Ferster, MD

Blood (2019) 134 (Supplement_1): 4847.

https://doi.org/10.1182/blood-2019-130294

Published: 2019

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

Does Hemoglobin S in Sickle Cell Trait and Sickle Cell Anemia Induce Higher Hemostatic Potential?

Bhavna Ansuya Mahadeb, MD, Laurence Rozen, PharmD, Denis Fondjie Noubouossie, Tatiana Besse-Hammer, Andre Efira, MD, Philippe Hermans, MD PhD, Beatrice Gulbis, MD PhD, Marie-Agnes Azerad, MD, Anne C Demulder, MD PhD

Blood (2014) 124 (21): 4924.

https://doi.org/10.1182/blood.V124.21.4924.4924

Published: 2014

Journal Articles

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Phu-Quoc Lê, MD, Alina Ferster, MD, Laurence Dedeken, MD, Laurence Rozen, PharmD, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Françoise Dresse, MD PhD, André Efira, MD, Samantha Benghiat, MD PhD, Sophie Dupont, MD, Beatrice Gulbis, MD PhD

Blood (2014) 124 (21): 4935.

https://doi.org/10.1182/blood.V124.21.4935.4935

Published: 2014

Journal Articles

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Phu-Quoc Lê, MD, Laurence Dedeken, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Samantha Benghiat, MD, André Efira, MD, Marie-Francoise Dresse, MD, Sophie Dupont, MD, Alina Ferster, MD

Blood (2013) 122 (21): 2231.

https://doi.org/10.1182/blood.V122.21.2231.2231

Published: 2013

Journal Articles

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Laurence Dedeken, MD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christiane Vermylen, MD, PhD, Sophie Huybrechts, MD, Christine Devalck, MD, Frederic Cotton, PhD, Ba Cuong Nguyen, Françoise Vertongen, MD, PhD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 4757.

https://doi.org/10.1182/blood.V120.21.4757.4757

Published: 2012

Journal Articles

National Clinical Data Base for Sickle Cell Disease In Belgium

Phu-Quoc Lê, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, André Efira, MD, Ba-Cuong Nguyen, Malou Ngalula Mujinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 2659.

https://doi.org/10.1182/blood.V116.21.2659.2659

Published: 2010

Journal Articles

Stroke Risk In Children with Sickle Cell Disease (SCD) Treated by Hydroxyurea (HU). A Belgian Center Experience

Nicolas Lefevre, MD, Dominique Dufour, MD, Beatrice Gulbis, MD, PhD, Phu-Quoc Le, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Alina Ferster, MD

Blood (2010) 116 (21): 2646.

https://doi.org/10.1182/blood.V116.21.2646.2646

Published: 2010

Journal Articles

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Françoise Vertongen, MD, PhD, Alina Ferster, MD

Blood (2010) 116 (21): 4823.

https://doi.org/10.1182/blood.V116.21.4823.4823

Published: 2010

Journal Articles

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Phu-Quoc Le, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Ba-Cuong Nguyen, Malou Ngalula Mijinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 4816.

https://doi.org/10.1182/blood.V116.21.4816.4816

Published: 2010

Journal Articles

Use of hydroxyurea in prevention of stroke in children with sickle cell disease

Nicolas Lefèvre, Dominique Dufour, Beatrice Gulbis, Phu-Quoc Lê, Catherine Heijmans, Alina Ferster

Blood (2008) 111 (2): 963–964.

https://doi.org/10.1182/blood-2007-08-102244

Published: 2008

NARROW

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Does Hemoglobin S in Sickle Cell Trait and Sickle Cell Anemia Induce Higher Hemostatic Potential?

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

National Clinical Data Base for Sickle Cell Disease In Belgium

Stroke Risk In Children with Sickle Cell Disease (SCD) Treated by Hydroxyurea (HU). A Belgian Center Experience

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Use of hydroxyurea in prevention of stroke in children with sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only